Clinical trials - Press Releases

Date	Title	Company
18-Aug-2021	Cidara Therapeutics and Mundipharma Announce Completion of Enrollment in the Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis	Cidara Therapeutics
18-Aug-2021	Tiziana Announces Publication of a Peer Reviewed Article on Data from the Clinical Trial with Intranasally Administered Foralumab, Its Proprietary Fully Human Anti-CD3 Monoclonal Antibody, in Mild to Moderate COVID-19 Patients in Brazil	Tiziana Life Sciences plc
17-Aug-2021	Cidara Therapeutics and Mundipharma Announce Completion of Enrollment in the Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis	Mundipharma
17-Aug-2021	Moderna Announces First Patient Dosed in Phase 1/2 Study of mRNA-3705 for Methylmalonic Acidemia	Moderna
17-Aug-2021	Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response and Protection in Preclinical Study	GSK
16-Aug-2021	Lilly's lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase 3 trials	Lilly
16-Aug-2021	Lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase 3 trials	Almirall S.A.
12-Aug-2021	iTeos Reports Second Quarter 2021 Financial Results and Provides Business Update	iTeos Therapeutics, Inc.
11-Aug-2021	PONVORY®▼ (ponesimod), a Once Daily, Oral Therapy Authorised in Great Britain for the Treatment of Adults with Relapsing Forms of Multiple Sclerosis (RMS) with Active Disease Defined by Clinical or Imaging Features	Janssen
11-Aug-2021	Precision for Medicine and Trialbee Partner to Advance Clinical Trials for Complex Therapies and Speed Shift Toward Precision Medicine	Precision for Medicine
09-Aug-2021	SCOTTISH MEDICINES CONSORTIUM (SMC) ACCEPTS TREMFYA®▼ (GUSELKUMAB), THE FIRST IL-23 p19 INHIBITOR TREATMENT, FOR ACTIVE PSORIATIC ARTHRITIS (PsA)	Janssen
05-Aug-2021	10 key reasons to join SMi's 2nd Annual Next Generation Pharmaceutical Cleanroom Conference	SMi Group
05-Aug-2021	Phase 3 trial of Libtayo® (cemiplimab) combined with chemotherapy stopped early due to significant improvement in overall survival in patients with first-line advanced non-small cell lung cancer	Sanofi
05-Aug-2021	Combination of the first component of Sputnik V vaccine (Sputnik Light vaccine) with vaccines by AstraZeneca, Sinopharm and Moderna demonstrates high safety profile during the study in Argentina’s Buenos-Aires province	The Russian Direct Investment Fund
05-Aug-2021	Nordic Nanovector Provides Update on PARADIGME, its Phase 2b Pivotal Trial with Betalutin® in R/R Follicular Lymphoma	Nordic Nanovector
04-Aug-2021	Exclusive Interview with Alexander Stoll, Fresenius Kabi AB speaker at SMi’s Aseptic Processing Conference	SMi Group
04-Aug-2021	Artificial Cornea and Corneal Implant Market – Rising Prevalence of Diabetes and Related Eye Diseases to Support Growth	MarketsandMarkets Research Private Ltd.
04-Aug-2021	The Most Widely Growth Strategies Adopted by Major Players Which are Advancing the Growth of Radiotherapy Market.	MarketsandMarkets Research Private Ltd.
04-Aug-2021	ClinTex (CTi) Launches CTi-OEM Blockchain Clinical Trial App	ClinTex (CTi)
02-Aug-2021	PHASTAR Names Charles Gelb as Chief Commercial Officer	PHASTAR